Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaClinical Consult: Assessing the Impact of Tailor XColorectal CancerGastrointestinal CancerGastrointestinal Cancer QuizHead & Neck CancerHER2-Positive Breast CancerImmune Thrombocytopenic PurpuraImmuno OncologyLymphomaRenal Cell CarcinomaTelehealth

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

All NewsNP/PAPractice ManagementTechnology

Clinical ConsultExpert InterviewsMedical World NewsTumor Board Series

CMEImage IQPodcastsPollsQuizzesSlideshowsToolkits

eNewsletterPrint Subscription

Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences and Cancer Network. All rights reserved.

Spotlight

Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Clinical Consult: Assessing the Impact of Tailor X
Colorectal Cancer
Gastrointestinal Cancer
Gastrointestinal Cancer Quiz
Head & Neck Cancer
HER2-Positive Breast Cancer
Immune Thrombocytopenic Purpura
Immuno Oncology
Lymphoma
Renal Cell Carcinoma
Telehealth

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences^™ and Cancer Network. All rights reserved.

ASCO 2010: New Treatments for CML

March 16, 2011

Dr. Jorge Cortes discusses new data on bosutinib, a new tyrosine kinase inhibitor for CML.